Exact Mass: 390.1653
Exact Mass Matches: 390.1653
Found 500 metabolites which its exact mass value is equals to given mass value 390.1653
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Compound II(R/S)
L-Ala-Gamma-D-Glu-Meso-Diaminopimelic Acid
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is found in herbs and spices. (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is a constituent of Zingiber officinale (ginger) Constituent of Zingiber officinale (ginger). (2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol is found in herbs and spices.
Rosmic acid
Rosmic acid is found in herbs and spices. Rosmic acid is a constituent of Rosmarinus officinalis (rosemary)
Tryptophyl-Tryptophan
Tryptophyl-Tryptophan is a dipeptied compoosed of two tryptophan residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Arctigenic acid
Flibanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist G - Genito urinary system and sex hormones Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].
Ethyl 5-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Serylvalylglycylglutamic acid
Production by Alternaria alternata on Helianthus annuus (sunflower). Serylvalylglycylglutamic acid is found in fats and oils.
Pseudolaric Acid C
CID 6440704 is a natural product found in Pseudolarix amabilis and Larix kaempferi with data available. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1]. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1].
Yocon
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
Pseudolaric
Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1]. Pseudolaric C is a diterpenoid isolated from the root bark of Pseudolarix amabilis, has antifungal activity[1].
[3aS-(3aalpha,4alpha,5alpha,9alpha,9aalpha,9bbeta)]-5-(Acetyloxy)-2,3,3a,4,5,9,9a,9b-octahydro-9-hydroxy-6,9-dimethyl-3-methylene-2-oxoazuleno[4,5-b]furan-4-yl ester 2-methylpropanoic acid
[3aS-(3aalpha,4alpha,5alpha,9beta,9aalpha,9bbeta)]-5-(Acetyloxy)-2,3,3a,4,5,9,9a,9b-octahydro-9-hydroxy-6,9-dimethyl-3-methylene-2-oxoazuleno[4,5-b]furan-4-yl ester 2-methylpropanoic acid
Rosmic acid
PD-0333941
CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5220; ORIGINAL_PRECURSOR_SCAN_NO 5217 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5221; ORIGINAL_PRECURSOR_SCAN_NO 5219 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5258; ORIGINAL_PRECURSOR_SCAN_NO 5256 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5239; ORIGINAL_PRECURSOR_SCAN_NO 5234 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5321; ORIGINAL_PRECURSOR_SCAN_NO 5318 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5240; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9763; ORIGINAL_PRECURSOR_SCAN_NO 9762 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9786; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9813; ORIGINAL_PRECURSOR_SCAN_NO 9811 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9834; ORIGINAL_PRECURSOR_SCAN_NO 9832 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9806; ORIGINAL_PRECURSOR_SCAN_NO 9804 CONFIDENCE standard compound; INTERNAL_ID 266; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9850; ORIGINAL_PRECURSOR_SCAN_NO 9846
(3beta,6alpha,8alpha)-3-(acetyloxy)-8-{[2-(hydroxymethyl)acryloyl]oxy}eudesma-1,11(13)-dieno-12,6-lactone|loloanolide A|rel-(3aR,4S,5aS,8S,9S,9aS,9bR)-8-(acetyloxy)-2,3,3a,4,5,5a,8,9,9a,9b-decahydro-5a,9-dimethyl-3-methylene-2-oxonaphto[1,2-b]furan-4-yl 2-(hydroxymethyl)prop-2-enoate
(3S,6R,7R,8R)-3-Hydroxy-8-acetoxysarracenyloxygermacra-1(10),4,11(13)-trien-6,12-olide
13-acetoxy-8alpha-methacryloyloxy-4beta-hydroxy-bourbon-7(11)-en-6,12-olide
15-O-butanedioylpodocarpen-5,8(14)-dien-6-hydroxy-7,13-dione|abiesanordine A
8-Ac,3-O-(3-methylbutanoyl)-2-(2,4-hexadiynylidene)-1,6-dioxaspiro[4.5]decane-3,4,8-triol
7-methoxy-8-[1-methoxy-2,4-dihydroxy-3-methylene-4-O-isovaleryl-butyl]coumarin|micromeloside C
(4R,6R,7S,8R,10S)-3-Oxo-8-acetoxysarracenyloxyjujuyensa-1,11(13)-dien-6,12-olide
(+)- justiciresinol|(+)-5-methoxylariciresinol|(+)-methoxylariciresinol
6-(2-Methylpropanoyl),8-Ac-(1alpha,5beta,6alpha,8beta,9beta,10alpha)-6,8-Dihydroxy-4-oxo-2,11(13)-pseudoguaiadien-12,9-olide|8-O-acetyl-desacyllinearifolin B-6-O-isobutyrate
3-Angeloyl,7-(2-methylpropanoyl),8-Ac-9,10-Epoxy-P-mentha-1,3,5-triene-3,7,8-triol|9-acetoxy-7-isobutyryloxy-8,10-dihydro-8,10-epoxythymol-angelate
methyl-3-(3-hydroxy-3,3-dimethylprop-1-enyl)-4-O-(beta-acetoxybutyryl)-coumarate
8-desacyl-2,3-trans-ereglomerulide-8-O-methacrylate
(+)-(6R,7S,8S)-5-methoxyisolariciresinol|(-)-5-Methoxyisolariciresinol|5-methoxy-(+)-isolariciresinol|lyoniresinol
1,7-Bis(3,4-dihydroxyphenyl)-3-acetoxy-5-hydroxyheptane
4,5,7-trihydroxy-3,3,5-trimethoxy-8,4-oxyneolign-7E-ene
(2R,3R,4S,5S)-6,8-dimethoxy-7-(3,7-dimethyl-4,5-epoxy-2-hydroxyocta-6-enyloxy)coumarin|altissimacoumarin F
(+)-7-methoxyariciresinol|(7S*,8R*,8S*)-3,3,7-trimethoxy-4,9,4-trihydroxy-8.8,7.0.9-lignan
(1R,3S,5S,6S)-1,5-epoxy-3,6-dihydroxy-1,7-bis(3-methoxy-4-hydroxyphenyl)heptane|kravanhol A
(2S,3aR,4S,5aR,10aR,10bR)-2-(2,5-dihydro-2-hydroxy-5-oxofuran-3-yl)-2-methoxy-3a,4,10b-trimethyl-3,3a,4,5,5a,9,10,10b-octahydro-2H,7H-naphtho[4a,4-b:1,8-b?c?]difuran-7-one|ciliatolide C
(3R*,7R*,8S*)-3-(2-Methyl)propanoyloxy-15-acetoxy-14-oxomelampa-1(10),4,11(13)-trien-8,12-olide
arctigenic acid|L-threo-4-Hydroxy-2-(4-hydroxy-3-methoxy-benzyl)-3-(3.4-dimethoxy-benzyl)-buttersaeure|L-threo-4-hydroxy-2-(4-hydroxy-3-methoxy-benzyl)-3-(3.4-dimethoxy-benzyl)-butyric acid
(2R*,3S*,7R*,8S*)-2,3-Epoxy-14-acetoxy-15-(2-methyl)propanoyloxymelampa-1(10),4,11(13)-trien-8-12-olide
(-)-caulerpenynol|7,7-C-didehydro-6-hydroxy-6,7-dihydrocaulerpenyne|caulerpenynol
(4bS,7R,8aR,9S,10S)-7-Formyloxy-4b,5,6,7,8,8a,9,10-octahydro-3,9,10-trihydroxy-4b,8,8-trimethyl-2-(2-propenyl)phenanthren-1,4-dion
(1(10)E,4Z,6alpha,8beta,9alpha)-9-ethoxy-6,15-dihydroxy-8-(2-methylacryloxy)-14-oxogermacra-1(10),4,11(13)-trieno-12,6-lactone|rel-(3aR,4R,5R,6E,10Z,11aS)-5-ethoxy-6-formyl-2,3,3a,4,5,8,9,11a-octahydro-10-(hydroxymethyl)-3-methylidene-2-oxocyclodeca[b]furan-4-yl 2-methylprop-2-enoate
6-(2-Methyl-2-propenoyl),1-Ac-(1alpha,6beta,10beta)-1,6,10-Trihydroxyfuranoeremophlian-9-one
(3R,6R,7R,8R)-3-Acetoxy-8-sarracenyloxyhelianga-1(10),4,11(13)-trien-6,12-olide
3beta-angeloyloxy-8beta-methoxyeremophil-7(11)-ene-12,8alpha(14beta,6alpha)-diolide|3??-Angeloyloxy-8??-methoxyeremophil-7(11)-ene-12,8??(14??,6??)-diolide
(4S,1E)-3-[(Z)-acetoxymethylene]-10,11-epoxy-7,11-dimethyldodeca-1,10-dien-8-yne-1,4-diyl diacetate|10,11-epoxycaulerpenyne
4-Butyryl-6-(2,4-dioxo-6-propyl-3,4-dihydro-2H-pyran-3-ylmethyl)-2,2-dimethyl-cyclohexan-1,3,5-trion|4-butyryl-6-(2,4-dioxo-6-propyl-3,4-dihydro-2H-pyran-3-ylmethyl)-2,2-dimethyl-cyclohexane-1,3,5-trione
7-(3,7-dimethyl-7-hydroxy-2,3-oxy-5-octenyl)oxyisofraxidin|altissimacoumarin A
(acetoxymethyl-methylene-oxo-[?]yl)methyl 2-methylpropanoate
(3R*,7R*,8S*)-3-Acetoxy-15-(2-methyl)propanoyloxy-14-oxomelampa-1(10),4,11(13)-trien-8,12-olide
15-acetoxy-1alpha-<4-hydroxymethacryloyloxy>-arbusculin B
Val Ala Ser Asp
Rauwolscine HCl
Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM. Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM.
Yocon
A plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION. See also: Yohimbine (has active moiety). Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
C21H26O7_(2E,4E)-6-{[(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl]oxy}-6-oxo-2,4-hexadienoic acid
Ala Ala Glu Thr
Ala Ala Thr Glu
Ala Cys Pro Thr
Ala Cys Thr Pro
Ala Asp Ser Val
Ala Asp Val Ser
Ala Glu Ala Thr
Ala Glu Thr Ala
Ala Pro Cys Thr
Ala Pro Thr Cys
Ala Ser Asp Val
Ala Ser Val Asp
Ala Thr Ala Glu
Ala Thr Cys Pro
Ala Thr Glu Ala
Ala Thr Pro Cys
Ala Val Asp Ser
Ala Val Ser Asp
Cys Ala Pro Thr
Cys Ala Thr Pro
Cys Pro Ala Thr
Cys Pro Thr Ala
Cys Thr Ala Pro
Cys Thr Pro Ala
Asp Ala Ser Val
Asp Ala Val Ser
Asp Gly Ile Ser
Asp Gly Leu Ser
Asp Gly Ser Ile
Asp Gly Ser Leu
Asp Gly Thr Val
Asp Gly Val Thr
Asp Ile Gly Ser
Asp Ile Ser Gly
Asp Leu Gly Ser
Asp Leu Ser Gly
Asp Ser Ala Val
Asp Ser Gly Ile
Asp Ser Gly Leu
Asp Ser Ile Gly
Asp Ser Leu Gly
Asp Ser Val Ala
Asp Thr Gly Val
Asp Thr Val Gly
Asp Val Ala Ser
Asp Val Gly Thr
Asp Val Ser Ala
Asp Val Thr Gly
Glu Ala Ala Thr
Glu Ala Thr Ala
Glu Gly Ser Val
Glu Gly Val Ser
Glu Ser Gly Val
Glu Ser Val Gly
Glu Thr Ala Ala
Glu Val Gly Ser
Glu Val Ser Gly
Gly Asp Ile Ser
Gly Asp Leu Ser
Gly Asp Ser Ile
Gly Asp Ser Leu
Gly Asp Thr Val
Gly Asp Val Thr
Gly Glu Ser Val
Gly Glu Val Ser
Gly Ile Asp Ser
Gly Ile Ser Asp
Gly Leu Asp Ser
Gly Leu Ser Asp
Gly Met Pro Ser
Gly Met Ser Pro
Gly Pro Met Ser
Gly Pro Ser Met
Gly Ser Asp Ile
Gly Ser Asp Leu
Gly Ser Glu Val
Gly Ser Ile Asp
Gly Ser Leu Asp
Gly Ser Met Pro
Gly Ser Pro Met
Gly Ser Val Glu
Met Gly Pro Ser
Met Gly Ser Pro
Met Pro Gly Ser
Met Pro Ser Gly
Met Ser Gly Pro
Met Ser Pro Gly
Pro Ala Cys Thr
Pro Ala Thr Cys
Pro Cys Ala Thr
Pro Cys Thr Ala
Pro Gly Met Ser
Pro Gly Ser Met
Pro Met Gly Ser
Pro Met Ser Gly
Pro Ser Gly Met
Pro Ser Met Gly
Pro Thr Ala Cys
Pro Thr Cys Ala
Ser Gly Met Pro
Ser Gly Pro Met
Ser Met Gly Pro
Ser Met Pro Gly
Ser Pro Gly Met
Ser Pro Met Gly
Thr Ala Cys Pro
Thr Ala Pro Cys
Thr Cys Ala Pro
Thr Cys Pro Ala
Thr Pro Ala Cys
Thr Pro Cys Ala
TRP-TRP
A dipeptide formed from two L-tryptophan residues.
5-{4-hydroxy-6-[2-(4-hydroxy-3-methoxyphenyl)ethyl]oxan-2-yl}-3-methoxybenzene-1,2-diol
[2-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]trimethylammonium
methyl (1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate,hydrochloride
ZK93423
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
2,8-Diazaspiro[5.5]undecane-1,3,7,9-tetrone, 2,8-bis(phenylmethyl)
N-[(2-chlorophenyl)methyl]-1-[4-[[(2-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites D004791 - Enzyme Inhibitors
epi-isochromophilone II
An azaphilone that is 7,8-dihydro-6H-isochromen-6-one substituted by a chloro group at position 5, a 3,5-dimethylhepta-1,3-dien-1-yl group at position 3, a hydroxy group at position 7, a methyl group at position 7 and a 2-oxopropyl group at position 8. Isolated from Chaetomium cupreum, it exhibits antifungal activity.
1-(3,4-Dimethoxyphenyl)sulfonyl-4-(2,6-dimethylphenyl)piperazine
4-[(2S,3R,4R)-4-[(4-hydroxy-3-methoxyphenyl)methyl]-3-(hydroxymethyl)oxolan-2-yl]-2,6-dimethoxyphenol
5-(7-(6-Chloro-4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole
Flibanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist G - Genito urinary system and sex hormones Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].
Yohimbine hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D009184 - Mydriatics D000089162 - Genitourinary Agents > D064804 - Urological Agents Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine. Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.
(-)-5-Methoxyisolariciresinol
A lignan that is 5,6,7,8-tetrahydronaphthalen-2-ol substituted by two hydroxymethyl groups at positions 6 and 7, a methoxy group at position 3 and a 4-hydroxy-3,5-dimethoxyphenyl group at position 8. It has been isolated from the stems of Sinocalamus affinis.
3-[(3,4-dimethoxyphenyl)methyl]-4-hydroxy-2-[(4-hydroxy-3-methoxyphenyl)methyl]butanoic acid
(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-hexylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate
2-[[4-Cyano-6,6,7-trimethyl-1-(4-morpholinyl)-5,8-dihydro-2,7-naphthyridin-3-yl]thio]acetic acid methyl ester
Cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester
3-(1-Methyl-2-benzimidazolyl)-1-phenyl-2-pyrrolo[3,2-b]quinoxalinamine
1-[2-(3,4-dimethoxyphenyl)ethyl]-6-propyl-2-sulfanylidene-7,8-dihydro-5H-pyrimido[4,5-d]pyrimidin-4-one
N-(2-furanylmethyl)-3-[3-[(4-methoxyphenyl)methyl]-2-imidazo[4,5-b]pyridinyl]propanamide
(4-Methylphenyl)-[4-[4-nitro-2-(1-pyrrolyl)phenyl]-1-piperazinyl]methanone
5-Methoxy-8-(2-hydroxy-3-buthoxy-3-methylbutyloxy)psoralen
A member of the class of psoralens that is psoralen substituted by a methoxy group at position 4 and a [(2R)-3-butoxy-2-hydroxy-3-methylbutyl]oxy group at position 9. Isolated from the roots of Angelica dahurica, it exhibits inhibitory activity against COX-2 and 5-lipooxygenase.
(2R,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2S,3R,4S)-3-[4-(cyclohexen-1-yl)phenyl]-1-(3-fluorobenzoyl)-4-(hydroxymethyl)azetidine-2-carbonitrile
(2S,3S,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
(2R,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-1-[(3-fluorophenyl)-oxomethyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
4-acetyl-1-[2-(1H-indol-3-yl)ethyl]-5-(3-methoxyphenyl)pyrrolidine-2,3-dione
3-[(2E)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-4-methyl-2-(2-phenylhydrazinylidene)-2H-pyrrol-3-yl]propanoic acid
methyl (3aR,4R,5R,6E,10E,11aR)-5-hydroxy-10-methyl-4-[(Z)-2-methylbut-2-enoyl]oxy-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
5-[7-[2-Chloro-4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]heptyl]-3-methyl-isoxazole
(2S,4S,6S)-2-[2-(4-Hydroxy-3-meyhoxyphenyl)ethyl]tetrahydro-6-(4,5-dihydroxy-3-methoxyphenyl)-2H-pyran-4-ol
(+)-5-methoxylariciresinol
A lignan that is (+)-lariciresinol substituted by a methoxy group at position 5. It has been isolated from the stems of Sinocalamus affinis.
Emraclidine
Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator (WO2018002760, compound 11). Emraclidine can be used for the research of neurological diseases[1].
(1r,2r,5r,6r,7s,8s)-2,8-dihydroxy-1-methoxy-7-(7-methoxy-2h-1,3-benzodioxol-5-yl)-6-methyl-5-(prop-2-en-1-yl)bicyclo[3.2.1]octan-3-one
(3as,4r,5s,9s,9as,9bs)-5-(acetyloxy)-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(1s,2r,5s,6r,9r,10r)-8-formyl-6,10-dihydroxy-4,4-dimethyl-12-oxo-11-oxatetracyclo[7.3.1.0¹,⁹.0²,⁶]tridec-7-en-5-yl (2z)-hex-2-enoate
8-(acetyloxy)-2-(hexa-2,4-diyn-1-ylidene)-4-hydroxy-1,6-dioxaspiro[4.5]decan-3-yl 3-methylbutanoate
14-methoxy-3-methyl-9-methylidene-8-oxo-4,7,15-trioxatetracyclo[11.2.1.0³,⁵.0⁶,¹⁰]hexadec-13(16)-en-11-yl 2-methylbut-2-enoate
(1s,2r,4r,6s,8r,9z,11s)-8-(acetyloxy)-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 2-methylprop-2-enoate
2-(hydroxymethyl)-1-methoxy-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradeca-2,12-dien-9-yl 2-methylbut-2-enoate
4-{hydroxy[(3s,4s)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl}-2,6-dimethoxyphenol
methyl 11-hydroxy-4-[(2-methylbut-2-enoyl)oxy]-3,10-dimethylidene-2-oxo-3ah,4h,5h,8h,9h,11h,11ah-cyclodeca[b]furan-6-carboxylate
(3ar,4r,9r,11ar)-9-(acetyloxy)-6,10-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl (2z)-2-hydroxybut-2-enoate
[(1r,3s,7r,9r)-1-[(acetyloxy)methyl]-6-methylidene-5-oxo-4,12-dioxatricyclo[7.5.0.0³,⁷]tetradeca-10,13-dien-10-yl]methyl 2-methylpropanoate
(2e,4e)-5-[(1r,7s,8r,9r)-7-hydroxy-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
8-hydroxy-4'-methyl-6,9-dimethylidene-2-oxo-octahydrospiro[azuleno[4,5-b]furan-3,2'-oxetan]-4-yl 2-(hydroxymethyl)prop-2-enoate
(3ar,4r,11ar)-10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(2s,3r,4s,5s,6r)-2-[3-hydroxy-2-methyl-5-(2-phenylethyl)phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2z,5z,9e)-2-[2-(2,5-dihydroxyphenyl)-2-oxoethylidene]-11-hydroxy-6-(hydroxymethyl)-10-methylundeca-5,9-dienoic acid
methyl (2s,4ar,6ar,10ar,10br)-2-[(5s)-5-hydroxy-2-oxo-5h-furan-3-yl]-6a,10b-dimethyl-4-oxo-1h,2h,4ah,5h,6h,9h,10h,10ah-naphtho[2,1-c]pyran-7-carboxylate
(3s,4s)-3-hydroxy-4-methoxy-4-(7-methoxy-2-oxochromen-8-yl)-2-methylidenebutyl 3-methylbutanoate
(1r)-1-(5,7-dimethoxy-2-oxochromen-8-yl)-3-methyl-2-oxobutyl 3-methylbutanoate
10-[(acetyloxy)methyl]-6-formyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-4-yl 2-methylpropanoate
(4ar,5s,6r,6as,11as,11br)-4a,6-dihydroxy-4,4,11b-trimethyl-1,7-dioxo-2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
[5,8-dihydroxy-7-(2-hydroxypropyl)-1,4a-dimethyl-6,10-dioxo-2,3,4,10a-tetrahydrophenanthren-1-yl]methyl formate
(1e,3z,4s,6e)-1-(acetyloxy)-3-[(acetyloxy)methylidene]-9-[(2r)-3,3-dimethyloxiran-2-yl]-7-methylnona-1,6-dien-8-yn-4-yl acetate
6-({9b-hydroxy-6,6,9a-trimethyl-1-oxo-3h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-5-yl}oxy)-6-oxohexa-2,4-dienoic acid
(7r,8r)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-hydroxy-7-methyl-8-(2-oxopropyl)-8h-isochromen-6-one
(3as,4r,5s,9r,9as,9bs)-5-(acetyloxy)-9-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
[(3ar,7s,11as)-7-(acetyloxy)-10-formyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-6-yl]methyl 2-methylpropanoate
methyl 6-(3-hydroxy-4,4-dimethyl-2,3-dihydro-1,5-benzodioxepin-7-yl)-2-(methoxymethylidene)-3-methyl-4-oxohex-5-enoate
2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether
{"Ingredient_id": "HBIN003642","Ingredient_name": "2-[2-(3,4-dihydroxyphenyl)ethyl]tetrahydro-6-(3,4,5-trihydroxyphenyl)-2h-pyran-4-ol; (2s,4s,6s)-form,3',3''-di-me ether","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "NA","Ingredient_weight": "390.43","OB_score": "NA","CAS_id": "182369-54-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8792","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-5'-methoxyisolariciresinol
{"Ingredient_id": "HBIN011760","Ingredient_name": "(?)-5'-methoxyisolariciresinol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)CC2COC(C2CO)C3=CC(=C(C=C3)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13969","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5'-methoxylariciresinol
{"Ingredient_id": "HBIN011764","Ingredient_name": "5'-methoxylariciresinol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC(=C1O)OC)C2C(C(CO2)CC3=CC(=C(C=C3)O)OC)CO","Ingredient_weight": "390.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13979","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44559567","DrugBank_id": "NA"}
5-methoxy-trans-dihydrodehydrodiconiferylalcohol
{"Ingredient_id": "HBIN011778","Ingredient_name": "5-methoxy-trans-dihydrodehydrodiconiferylalcohol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=CC(=CC2=C1OC(C2CO)C3=CC(=C(C(=C3)OC)O)OC)CCCO","Ingredient_weight": "390.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13900","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "56838440","DrugBank_id": "NA"}
6,7-dimethoxy-coumarin-8-hydroxy
{"Ingredient_id": "HBIN012081","Ingredient_name": "6,7-dimethoxy-coumarin-8-hydroxy","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "CC(C1C(O1)C=C(C)C)C(COC2=C(C=C3C=CC(=O)OC3=C2OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41945","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-8-methoxyisolariciresinol
{"Ingredient_id": "HBIN013815","Ingredient_name": "(?)-8-methoxyisolariciresinol","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "COC1=C(C(=C2C(C(C(CC2=C1)CO)CO)C3=CC(=C(C=C3)O)OC)OC)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13968","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
altissimacouniarin G
{"Ingredient_id": "HBIN015783","Ingredient_name": "altissimacouniarin G","Alias": "NA","Ingredient_formula": "C21H26O7","Ingredient_Smile": "CC(=CC1CC(C(O1)COC2=C(C=C3C=CC(=O)OC3=C2OC)OC)(C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "34516","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}